AVRO Latest Press Releases, AVROBIO Corporate News

Releases

0.00%

All
Financials
Insiders

4 AVROBIO, Inc. (0001681087) (Issuer)
Feb 18,2021 19:06
SC 13G/A AVROBIO, Inc. (0001681087) (Subject)
Feb 16,2021 16:30
SC 13D/A AVROBIO, Inc. (0001681087) (Subject)
Feb 16,2021 16:02
8-K AVROBIO, Inc. (0001681087) (Filer)
Feb 08,2021 07:57
4 AVROBIO, Inc. (0001681087) (Issuer)
Feb 04,2021 17:51
4 AVROBIO, Inc. (0001681087) (Issuer)
Feb 04,2021 17:53
4 AVROBIO, Inc. (0001681087) (Issuer)
Feb 04,2021 17:55
4 AVROBIO, Inc. (0001681087) (Issuer)
Feb 04,2021 17:56
4 AVROBIO, Inc. (0001681087) (Issuer)
Feb 02,2021 16:55
3 AVROBIO, Inc. (0001681087) (Issuer)
Jan 22,2021 16:54
SC 13G/A AVROBIO, Inc. (0001681087) (Subject)
Jan 20,2021 13:08
8-K AVROBIO, Inc. (0001681087) (Filer)
Jan 11,2021 07:01
Form8-K AVROBIO, Inc.
Nov 20,2020 16:08
Form424B5 AVROBIO, Inc.
Nov 20,2020 16:03
Form424B5 AVROBIO, Inc.
Nov 19,2020 16:15
Form8-K AVROBIO, Inc.
Nov 17,2020 09:07
Form8-K AVROBIO, Inc.
Nov 17,2020 07:39
FormSC 13G/A AVROBIO, Inc.
Nov 09,2020 12:50
10-Q AVROBIO, Inc.
Nov 05,2020 17:05
8-K AVROBIO, Inc.
Nov 05,2020 07:18
Form4 AVROBIO, Inc.
Oct 21,2020 16:24
Form3 AVROBIO, Inc.
Oct 21,2020 16:22
Form8-K AVROBIO, Inc.
Oct 21,2020 08:19
Form8-K AVROBIO, Inc.
Oct 06,2020 08:29
Form8-K AVROBIO, Inc.
Oct 05,2020 07:10
FormS-8 AVROBIO, Inc.
Aug 06,2020 07:28
Form8-K AVROBIO, Inc.
Aug 06,2020 07:07
Form10-Q AVROBIO, Inc.
Aug 06,2020 07:11
8-K AVROBIO, Inc. (0001681087) (Filer)
Jul 06,2020 07:35
8-K AVROBIO, Inc. (0001681087) (Filer)
Jun 16,2020 08:24
8-K AVROBIO, Inc. (0001681087) (Filer)
Jun 09,2020 16:30
Form4 AVROBIO, Inc.
Jun 05,2020 17:06
4 AVROBIO, Inc. (0001681087) (Issuer)
Jun 05,2020 17:18
4 AVROBIO, Inc. (0001681087) (Issuer)
Jun 05,2020 17:15
4 AVROBIO, Inc. (0001681087) (Issuer)
Jun 05,2020 17:13
4 AVROBIO, Inc. (0001681087) (Issuer)
Jun 05,2020 17:09
4 AVROBIO, Inc. (0001681087) (Issuer)
Jun 05,2020 17:11
8-K AVROBIO, Inc. (0001681087) (Filer)
May 14,2020 07:05
8-K AVROBIO, Inc. (0001681087) (Filer)
May 13,2020 07:06
10-Q AVROBIO, Inc.
May 07,2020 16:01
8-K AVROBIO, Inc. (0001681087) (Filer)
May 07,2020 07:06
DEFA14A AVROBIO, Inc. (0001681087) (Filer)
Apr 22,2020 16:36
8-K AVROBIO, Inc.
Apr 03,2020 08:01
8-K AVROBIO, Inc.
Mar 30,2020 16:50
10-K AVROBIO, Inc.
Mar 16,2020 16:02
S-8 AVROBIO, Inc. (0001681087) (Filer)
Mar 16,2020 16:32
8-K AVROBIO, Inc. (0001681087) (Filer)
Mar 16,2020 07:11
4 AVROBIO, Inc. (0001681087) (Issuer)
Mar 06,2020 16:41
4 AVROBIO, Inc. (0001681087) (Issuer)
Mar 06,2020 16:38
3 AVROBIO, Inc. (0001681087) (Issuer)
Mar 06,2020 16:35

Webull provides the latest AVROBIO (AVRO) stock and general news. This information may help you make smarter investment decisions.

About AVRO

AVROBIO, Inc. is a clinical-stage gene therapy company. The Company is focused on developing curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose. Its gene therapies employ hematopoietic stem cells that are extracted from the patient and then modified with lentiviral vectors to insert a functional copy of the gene that is defective in the target disease. Its product pipeline includes AVR-RD-01, AVR-RD-02, AVR-RD-03 and AVR-RD-04. The Company is developing AVR-RD-01 for the treatment of Fabry disease. AVR-RD-02 is the Company’s gene therapy for Gaucher disease. AVR-RD-03 is being developed for the treatment of Pompe disease. The Company is developing AVR-RD-04 for the treatment of patients with cystinosis.